Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
67.90
+0.70 (1.04%)
Apr 24, 2025, 1:30 PM CST
-2.86%
Market Cap 3.02B
Revenue (ttm) 611.42M
Net Income (ttm) 84.12M
Shares Out 44.93M
EPS (ttm) 1.86
PE Ratio 36.15
Forward PE n/a
Dividend 1.75 (2.59%)
Ex-Dividend Date Jun 21, 2024
Volume 16,320
Average Volume 143,034
Open 67.50
Previous Close 67.20
Day's Range 67.10 - 67.90
52-Week Range 58.00 - 88.30
Beta -0.22
RSI 40.28
Earnings Date Mar 28, 2025

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded... [Read more]

Sector Healthcare
Founded 1959
Employees 171
Stock Exchange Taipei Exchange
Ticker Symbol 4747
Full Company Profile

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.

Financial Statements

News

There is no news available yet.